Similar Natural Products in NPASS
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC215597 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 161 |
0.1-0.2 | 13877 |
0.2-0.3 | 12646 |
0.3-0.4 | 2687 |
0.4-0.5 | 1361 |
0.5-0.6 | 149 |
0.6-0.7 | 7 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 1 |
  Similar Clinical/Approved Drugs
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC215597 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
range |
Tanimoto Coefficient |
0-0.1 | 148 |
0.1-0.2 | 1021 |
0.2-0.3 | 3127 |
0.3-0.4 | 3126 |
0.4-0.5 | 1575 |
0.5-0.6 | 162 |
0.6-0.7 | 2 |
0.7-0.8 | 0 |
0.8-0.85 | 0 |
0.85-0.9 | 0 |
0.9-0.95 | 0 |
0.95-1 | 0 |
Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.6261 |
Remote Similarity |
NPD8835 |
Approved |
0.605 |
Remote Similarity |
NPD9101 |
Discontinued |
0.5882 |
Remote Similarity |
NPD3576 |
Approved |
0.5882 |
Remote Similarity |
NPD3575 |
Approved |
0.5864 |
Remote Similarity |
NPD565 |
Phase 2 |
0.5772 |
Remote Similarity |
NPD9472 |
Phase 3 |
0.5705 |
Remote Similarity |
NPD9596 |
Approved |
0.5705 |
Remote Similarity |
NPD9595 |
Approved |
0.5687 |
Remote Similarity |
NPD1418 |
Phase 2 |
0.566 |
Remote Similarity |
NPD9574 |
Clinical (unspecified phase) |
0.5655 |
Remote Similarity |
NPD715 |
Phase 3 |
0.5643 |
Remote Similarity |
NPD2225 |
Clinical (unspecified phase) |
0.5607 |
Remote Similarity |
NPD1033 |
Clinical (unspecified phase) |
0.5607
|
Remote Similarity |
NPD1034 |
Phase 3 |